These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 9791177)

  • 1. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics.
    Brötz H; Josten M; Wiedemann I; Schneider U; Götz F; Bierbaum G; Sahl HG
    Mol Microbiol; 1998 Oct; 30(2):317-27. PubMed ID: 9791177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
    Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
    Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of antibiotic mechanisms in lantibiotics.
    Hoffmann A; Pag U; Wiedemann I; Sahl HG
    Farmaco; 2002 Aug; 57(8):685-91. PubMed ID: 12361237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mode of action of lipid II-targeting lantibiotics.
    Bauer R; Dicks LM
    Int J Food Microbiol; 2005 May; 101(2):201-16. PubMed ID: 15862882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles.
    Driessen AJ; van den Hooven HW; Kuiper W; van de Kamp M; Sahl HG; Konings RN; Konings WN
    Biochemistry; 1995 Feb; 34(5):1606-14. PubMed ID: 7849020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
    Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
    Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
    Tol MB; Morales Angeles D; Scheffers DJ
    Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
    Bonelli RR; Schneider T; Sahl HG; Wiedemann I
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
    Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
    Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
    Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
    J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
    Breukink E; Wiedemann I; van Kraaij C; Kuipers OP; Sahl HG; de Kruijff B
    Science; 1999 Dec; 286(5448):2361-4. PubMed ID: 10600751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.
    Brötz H; Bierbaum G; Leopold K; Reynolds PE; Sahl HG
    Antimicrob Agents Chemother; 1998 Jan; 42(1):154-60. PubMed ID: 9449277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria.
    Héchard Y; Sahl HG
    Biochimie; 2002; 84(5-6):545-57. PubMed ID: 12423799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Dynamics Insight into the Lipid II Recognition by Type A Lantibiotics: Nisin, Epidermin, and Gallidermin.
    Panina I; Taldaev A; Efremov R; Chugunov A
    Micromachines (Basel); 2021 Sep; 12(10):. PubMed ID: 34683220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of GdmH in producer immunity and secretion of the Staphylococcal lantibiotics gallidermin and epidermin.
    Hille M; Kies S; Götz F; Peschel A
    Appl Environ Microbiol; 2001 Mar; 67(3):1380-3. PubMed ID: 11229936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7.
    van de Kamp M; van den Hooven HW; Konings RN; Bierbaum G; Sahl HG; Kuipers OP; Siezen RJ; de Vos WM; Hilbers CW; van de Ven FJ
    Eur J Biochem; 1995 Jun; 230(2):587-600. PubMed ID: 7607233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the pore forming-peptide antibiotics Pep 5, nisin and subtilin with non-energized liposomes.
    Kordel M; Schüller F; Sahl HG
    FEBS Lett; 1989 Feb; 244(1):99-102. PubMed ID: 2924913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity.
    Scherer K; Wiedemann I; Ciobanasu C; Sahl HG; Kubitscheck U
    Biochim Biophys Acta; 2013 Nov; 1828(11):2628-36. PubMed ID: 23872123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lantibiotics, a class of ribosomally synthesized peptide antibiotics].
    Entian KD; Klein C
    Naturwissenschaften; 1993 Oct; 80(10):454-60. PubMed ID: 8264800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
    Bierbaum G; Götz F; Peschel A; Kupke T; van de Kamp M; Sahl HG
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):119-127. PubMed ID: 8775972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.